المؤلفون: Amit U; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Radiation Oncology, Tel Aviv Medical Center, Tel Aviv, Israel., Shagun M; Department of Radiotherapy, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India., Plastaras JP; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Metz JM; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Karasic TB; Department of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lubas MJ; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Ben-Josef E; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Edgar.Ben-Josef@pennmedicine.upenn.edu.

المصدر: Radiation oncology (London, England) [Radiat Oncol] 2024 Aug 01; Vol. 19 (1), pp. 102. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Biliary Tract Neoplasms*/radiotherapy , Biliary Tract Neoplasms*/mortality , Biliary Tract Neoplasms*/pathology, Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Aged ; Prognosis ; Adult ; Aged, 80 and over ; Survival Rate ; Risk Assessment

المؤلفون: Lubas MJ; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Santos PMG; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yerramilli D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Simone CB 2nd; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; New York Proton Center, New York, NY, USA.

المصدر: Annals of palliative medicine [Ann Palliat Med] 2023 Nov; Vol. 12 (6), pp. 1331-1344. Date of Electronic Publication: 2023 Aug 04.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101585484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2224-5839 (Electronic) Linking ISSN: 22245820 NLM ISO Abbreviation: Ann Palliat Med Subsets: MEDLINE

مواضيع طبية MeSH: Proton Therapy* , Neoplasms*/radiotherapy, Adult ; Humans ; Retrospective Studies ; Quality of Life ; Prospective Studies

المؤلفون: Reiss KA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. kim.reissbinder@pennmedicine.upenn.edu gregory.beatty@pennmedicine.upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Wattenberg MM; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Damjanov N; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Prechtel Dunphy E; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Jacobs-Small M; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Lubas MJ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Robinson J; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Dicicco L; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Garcia-Marcano L; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Giannone MA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Karasic TB; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Furth EE; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Carpenter EL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Wojcieszynski AP; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Vonderheide RH; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Beatty GL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. kim.reissbinder@pennmedicine.upenn.edu gregory.beatty@pennmedicine.upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Ben-Josef E; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Feb; Vol. 20 (2), pp. 389-397. Date of Electronic Publication: 2020 Dec 02.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular/*drug therapy , Liver Neoplasms/*drug therapy , Pyrazoles/*therapeutic use , Quinolines/*therapeutic use, Aged ; Humans ; Male ; Middle Aged ; Pilot Projects ; Pyrazoles/pharmacology ; Quinolines/pharmacology ; Radiosurgery

المؤلفون: Lubas MJ; Philadelphia College of Osteopathic Medicine, Philadelphia, USA., Kumar SS; Fox Chase Cancer Center, Department of Radiation Oncology, Philadelphia, PA, 19111, USA. Sameera.kumar@fccc.edu.

المصدر: Current oncology reports [Curr Oncol Rep] 2020 Sep 15; Vol. 22 (12), pp. 117. Date of Electronic Publication: 2020 Sep 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy* , Radiosurgery*, Carcinoma, Non-Small-Cell Lung/*therapy , Lung Neoplasms/*therapy, Clinical Trials as Topic ; Combined Modality Therapy ; Humans ; Immune Checkpoint Inhibitors/therapeutic use